REST Trial
About the project: REST Trial - Randomised trial of an intervention targeting self-efficacy to self-manage cancer-related fatigue in people with a primary brain tumour
Who can take part?
We are seeking people who:
Are aged 18 years or older
Have been diagnosed with a malignant brain tumour in the past
Experience fatigue
Have or are willing to create an email account and have access to the internet
What participation involves
A brief phone call to confirm the study is suitable for you
A short online survey asking for some information about you
Doing an online program with six sessions across 12 weeks
You will fill out a brief online survey 3 times during the study
You may be asked to take part in an interview about your experiences of being in this study
You can complete the program on your own or with support from a family caregiver or another person. Your choice will be recorded when you begin the program.
If you are a patient and would like to participate in this trial please contact the research team at:
If you are a clinician and would like to refer patients to this trial please contact the research team at:
The ethical aspects of this study have been approved by the Human Research Ethics Committees (HREC) of The University of Sydney [ethics reference: 2025/HE000433] and the Sydney Local Health District (CRGH Zone) [ethics reference: 2025/ETH01130].
REST is a randomised controlled trial being conducted by researchers at the University of Sydney to examine the efficacy of a novel online program in helping people with a primary brain tumour to better manage their fatigue.